Brought to you by 
St. Jude buys $10mm worth of InControl; gets no technology
13 Jul 1999
Executive Summary
St. Jude Medical took its first step into cardiac rhythm management with its purchase of 1.145mm shares of preferred stock in InControl (developing an implantable atrial defibrillator), as part of InControl's 2.42mm share Series E financing.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
St. Jude buys $10mm worth of InControl; gets no technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice